Related Experiment Video

Updated: Mar 1, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
14:20

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

17.2K

Hyaluronate-Lipid Nanohybrids: Fruitful Harmony in Cancer Targeting

May S Freag1

  • 1Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Alexandria 21521, Egypt.

Current Pharmaceutical Design
|May 30, 2017
PubMed

Insights

Hyaluronic acid (HA) targets cancer cells by binding to CD44 receptors. This review explores recent advances in using HA-functionalized lipid nanoparticles for improved cancer therapy and imaging.

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Oncology

Background:

  • Targeted drug delivery aims to enhance cancer treatment efficacy and reduce side effects.
  • Hyaluronic acid (HA) is a polysaccharide that selectively binds to CD44 receptors, which are overexpressed on many cancer cells.
  • Lipid nanoparticles (LNPs) are versatile carriers for therapeutic agents.

Purpose of the Study:

  • To review the role of hyaluronic acid in cancer targeting.
  • To highlight recent advancements in HA-functionalized lipid nanoparticles for cancer therapy.
  • To discuss the application of these nanoparticles in cancer imaging.

Main Methods:

  • Literature review of studies on hyaluronic acid, CD44 receptor, lipid nanoparticles, and cancer therapy.
  • Analysis of research focusing on the design and application of HA-modified LNPs.
  • Synthesis of information on the therapeutic and imaging potential of HA-targeted LNPs.

Main Results:

  • HA serves as an effective targeting ligand for cancer cells overexpressing CD44.
  • HA-functionalized LNPs demonstrate enhanced tumor accumulation and cellular uptake.
  • These targeted nanoparticles show promise for improved drug delivery and diagnostic imaging in cancer.

Conclusions:

  • Hyaluronic acid-based targeting strategies significantly improve the specificity of drug delivery to tumors.
  • HA-functionalized lipid nanoparticles represent a promising platform for next-generation cancer therapeutics and diagnostics.
  • Further research into HA-LNP systems can lead to more effective and personalized cancer treatments.
Keywords:
CD44 receptorsCancer targetingHyaluronic acidLipid nanoparticlespolysaccharide.tumor

More Related Videos

Micropatterned Surfaces to Study Hyaluronic Acid Interactions with Cancer Cells10:13

Micropatterned Surfaces to Study Hyaluronic Acid Interactions with Cancer Cells

Published on: December 22, 2010

15.6K
Synthesis and Characterization of Placental Chondroitin Sulfate A plCSA-Targeting Lipid-Polymer Nanoparticles05:55

Synthesis and Characterization of Placental Chondroitin Sulfate A plCSA-Targeting Lipid-Polymer Nanoparticles

Published on: September 18, 2018

9.4K

Related Concept Videos

Site-Targeted Drug Delivery Systems: Polymeric Carriers01:24

Site-Targeted Drug Delivery Systems: Polymeric Carriers

Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
63
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.0K
Modified-Release Drug Delivery Systems: Site-Targeted01:24

Modified-Release Drug Delivery Systems: Site-Targeted

Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
51